CoChat

CDK4/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment Failure

Open access
Garrido-Castro, Ana C., Goel, Shom · 2017 · Current Breast Cancer Reports
Cited by 69

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Purpose of reviewThe purpose of this review is to describe the role of D-type cyclins and cyclin-dependent kinases (CDKs) 4 and 6 in breast cancer and to discuss potential biomarkers for sensitivity or resistance to CDK4/6 inhibitors.Recent findingsA small number of preclinical and clinical studies have explored potential mechanisms of CDK4/6 inhibitor response and resistance in breast cancer. Putative markers of response include estrogen receptor positivity, luminal patterns of gene expression, high cyclin D1 levels, and low p16 levels. Possible resistance mechanisms include loss of Rb function, overexpression/amplification of cyclin E, and CDK6 amplification. Most of these remain speculative and have not been validated in clinical specimens.SummaryIf early successes with CDK4/6 inhibitors are to be capitalized upon, it is critical that our understanding of CDK4/6 biology in breast cancer extends beyond its current rudimentary state. Only then, we will be able to develop rational therapeutic combinations that further enhance the efficacy of these agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12609-017-0232-0

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 69

Metadata

Authors
Garrido-Castro, A. C., & Goel, S.
Venue
Current Breast Cancer Reports
Published
2017-02-01
Volume
9
Issue
1
Pages
26-33
ISSN
  • 1943-4588 (ISSN-L)
  • 1943-4596
OpenAlex
W2583538213
Cited by
69
References
27
FWCI
7.09
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CDK4/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment Failure. https://app.cochat.ai/papers/10.1007/s12609-017-0232-0
The paper
Garrido-Castro, A. C., & Goel, S. (2017). CDK4/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment Failure. Current Breast Cancer Reports. https://doi.org/10.1007/s12609-017-0232-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.